Reduced Tissue Damage and Improved Recovery of Motor Function after Traumatic Brain Injury in Mice Deficient in Complement Component C4
Open Access
- 25 April 2007
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 27 (12) , 1954-1964
- https://doi.org/10.1038/sj.jcbfm.9600497
Abstract
Complement component C4 mediates C3-dependent tissue damage after systemic ischemia—reperfusion injury. Activation of C3 also contributes to the pathogenesis of experimental and human traumatic brain injury (TBI); however, few data exist regarding the specific pathways (classic, alternative, and lectin) involved. Using complement knockout mice and a controlled cortical impact (CCI) model, we tested the hypothesis that the classic pathway mediates secondary damage after TBI. After CCI, C4c and C3d immunostaining were detected in cortical vascular endothelial cells in wild-type (WT) mice; however, C4c and C3d immunostaining were also detected in C1q−1/−mice, and C3d immunostaining was detected in C4−/−mice. After CCI, WT and C1q−1/−mice had similar motor deficits, Morris water maze performance, and brain lesion size. Naive C4−/−and WT mice did not differ in baseline motor performance, but C4−/−mice had reduced postinjury motor deficits (days 1 to 7, P < 0.05) and decreased brain tissue damage (days 14 and 35, P < 0.05) versus WT. Reconstitution of C4−/−mice with human C4 (hC4) reversed their protection against postinjury motor deficits ( P < 0.05 versus vehicle), but administration of hC4 did not impair postinjury motor performance (versus vehicle) in WT mice. The protective effects of C4−/−were functionally distinct from the classic pathway and terminal complement, as C1q−/−and C3−/−mice had postinjury tissue damage and motor dysfunction similar to WT. Thus, C4 contributes to motor deficits and brain tissue damage after CCI by mechanism(s) fundamentally different from those involved in experimental systemic ischemia-reperfusion injury.Keywords
This publication has 37 references indexed in Scilit:
- Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injuryExperimental Neurology, 2006
- boc-Aspartyl(OMe)-Fluoromethylketone Attenuates Mitochondrial Release of Cytochrome c and Delays Brain Tissue Loss after Traumatic Brain Injury in RatsJournal of Cerebral Blood Flow & Metabolism, 2006
- Traumatic Brain Injury in Mice Deficient in Bid: Effects on Histopathology and Functional OutcomeJournal of Cerebral Blood Flow & Metabolism, 2006
- C1q-Deficiency Is Neuroprotective Against Hypoxic-Ischemic Brain Injury in Neonatal MiceStroke, 2005
- A Murine Model for Neuropsychiatric Disorders Associated with Group A β-Hemolytic Streptococcal InfectionJournal of Neuroscience, 2004
- Ischaemia–reperfusion is an event triggered by immune complexes and complementBritish Journal of Surgery, 2003
- Complement C4 Inhibits Systemic Autoimmunity through a Mechanism Independent of Complement Receptors Cr1 and Cr2The Journal of Experimental Medicine, 2000
- THE ROLE OF COMPLEMENT AND COMPLEMENT RECEPTORS IN INDUCTION AND REGULATION OF IMMUNITYAnnual Review of Immunology, 1998
- A Targeted Disruption of the Murine Complement Factor B Gene Resulting in Loss of Expression of Three Genes in Close Proximity, Factor B, C2, and D17H6S45Published by Elsevier ,1998
- Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injuryJournal of Neuroimmunology, 1997